Disease/Infection News

RSS

Ebola survivors experienced a resurgence in antibody levels after recovery

A high proportion of survivors of Ebola experienced a resurgence in antibody levels nearly a year after recovery, a new University of Liverpool study has found.

27 Jan 2021

New tool offers data-driven, precision medicine approach to help scientists better understand COVID-19

It is called PAGER-CoV, and it promises to be an important tool in finding therapies for COVID-19.

27 Jan 2021

Temperature, latitude correlate with COVID-19 cases and mortality rates

With cities around the globe locking down yet again amid soaring COVID-19 numbers, could seasonality be partially to blame? New research from the University of Illinois says yes.

27 Jan 2021

R&D lacking on emerging infectious diseases, report finds

As research into COVID-19 swells, R&D on other infectious diseases is seriously lacking, report finds.

27 Jan 2021

New trial to look at reducing transmission of Covid-19 in care homes

A new trial, led by experts from the University of Nottingham, will look at reducing the transmission of Covid-19 and its severity in care homes, thanks to funding from the National Institute for Health Research.

27 Jan 2021

Biliverdin shields SARS-CoV-2 from host antibody response, study finds

A team of international scientists has recently revealed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) interacts with two heme metabolites, bilirubin and biliverdin, to escape the antibody-mediated host immune responses.

27 Jan 2021

Anakinra shows therapeutic potential in critically ill COVID-19 patients

A team of international scientists recently conducted an open-level clinical trial to investigate the effects of personalized immunotherapy on critically ill COVID-19 patients.

27 Jan 2021

CDC researchers back U.S. school re-openings but with strict COVID-19 regulations

As the U.S. continues to grapple with surging cases and the complex logistics of mass vaccination, is the country in a position to fully re-open its schools for in-person learning? Researchers at the Centers for Disease Control and Prevention (CDC) think so – notwithstanding a few very important caveats.

27 Jan 2021

COVID-19 will impact cardiovascular disease deaths for years to come, warn experts

Heart disease remains the leading cause of death worldwide, according to the American Heart Association's Heart Disease and Stroke Statistics -- 2021 Update, published today in the Association's flagship journal Circulation, and experts warn that the broad influence of the COVID-19 pandemic will likely continue to extend that ranking for years to come.

27 Jan 2021

Could spironolactone treat COVID-19-related pneumonia and pulmonary fibrosis?

Researchers have described the potential of the drug spironolactone, a potassium-sparing diuretic, and anti-androgen, in preventing or alleviating the severity of COVID-19 pneumonia, and in preventing pulmonary fibrosis.

27 Jan 2021

What do we know about the SARS-CoV-2 vaccines so far?

A new study surveys what we know so far about SARS-CoV-2 vaccine candidates from advanced clinical trials.

27 Jan 2021

Purdue University-affiliated startup receives NSF grant to study severe COVID-19 cases

A Purdue University-affiliated startup is receiving national support to pursue a strategy to treat severe COVID-19 cases and possible future outbreaks involving other viruses.

27 Jan 2021

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug

Allarity Therapeutics of Hørsholm, Denmark, today announced plans to further test the antiviral activity of stenoparib, its PARP inhibitor, against SARS-CoV-2 lineage B.1.1.7, also known as Coronavirus Variant B117 (the "British variant"), at the COVID-19 Testing Service Center (CTSC) of Northern Arizona University's Pathogen and Microbiome Institute (PMI), a leading U.S. infectious disease testing center.

27 Jan 2021

Certain malaria parasites use a mechanism to cross the blood–brain barrier

Malaria is one of the most common causes of death in children in Africa and is triggered by a small parasite that lives in the blood. When the parasite builds up in the blood vessels of the brain, it develops into one of the most dangerous forms of the disease, cerebral malaria.

27 Jan 2021

Medicaid expansion helps detect more numbers of undiagnosed HIV infections

The Medicaid expansion facilitated by the Affordable Care Act led to increases in the identification of undiagnosed HIV infections and in the use of HIV prevention services such as preexposure prophylaxis drugs, says new research co-written by a team of University of Illinois Urbana-Champaign experts who study the intersection of health care and public policy.

27 Jan 2021

Eviction moratoria and relief from utility disconnections reduce COVID-19 cases

Policies that helped financially struggling Americans stay in their homes and keep access to water and electricity during the COVID-19 pandemic also helped reduce the spread of the virus, according to a new analysis by Duke University researchers.

27 Jan 2021

New ACR Steering Committee established to guide diagnostic testing during COVID-19 pandemic

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today announced the formation of the AMP COVID Response (ACR) Steering Committee to help coordinate and communicate the organization's continued efforts to guide diagnostic testing during the ongoing COVID-19 pandemic and preparations for future emerging outbreaks.

27 Jan 2021

Disease/Infection News

Ebola survivors experienced a resurgence in antibody levels after recovery

New tool offers data-driven, precision medicine approach to help scientists better understand COVID-19

Temperature, latitude correlate with COVID-19 cases and mortality rates

R&D lacking on emerging infectious diseases, report finds

New trial to look at reducing transmission of Covid-19 in care homes

Biliverdin shields SARS-CoV-2 from host antibody response, study finds

Anakinra shows therapeutic potential in critically ill COVID-19 patients

CDC researchers back U.S. school re-openings but with strict COVID-19 regulations

COVID-19 will impact cardiovascular disease deaths for years to come, warn experts

Could spironolactone treat COVID-19-related pneumonia and pulmonary fibrosis?

What do we know about the SARS-CoV-2 vaccines so far?

Purdue University-affiliated startup receives NSF grant to study severe COVID-19 cases

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug

Certain malaria parasites use a mechanism to cross the blood–brain barrier

Medicaid expansion helps detect more numbers of undiagnosed HIV infections

Eviction moratoria and relief from utility disconnections reduce COVID-19 cases

New ACR Steering Committee established to guide diagnostic testing during COVID-19 pandemic

Study sheds new light on digital contact tracing to control the spread of COVID-19

Survey: 74% of respondents consider national vaccination strategy to be appropriate

Study: Use of online messaging and social media apps spiked during COVID-19 pandemic

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News